This program will take a deep dive into the latest data from that trial, with expert discussion about application to current patient populations.
CME ACCREDITATION AND DESIGNATION
The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cardiovascular Research Foundation designates this activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Documentation of awarded credit is provided for participants in exchange for completed activity evaluations. Evaluation by questionnaire will address content, presentation effectiveness, possible bias, and future educational needs.
To obtain CME credit for this activity, participants must review all CME information, view all presentations in their entirety, and complete the Activity Evaluation Form. If you have any questions, please contact Anjelica Scaletta-Resias at ascalettaresias@crf.org .
By the end of this program, participants should be able to:
• Understand the differing technology of TEER devices.
• Gain an in-depth understanding of the results of CLASP IID.
• Understand the nuances of the echocardiographic findings of patients enrolled in the CLASP trials
This educational activity is designed for Interventional Cardiologists, Cardiac Surgeons, and Echocardiologists.
It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and therefore, does not compromise the scientific integrity of the educational activity.
Discussion of off-label product usage is made at the sole discretion of the faculty. Off-label product discussion and usage is not endorsed by the Cardiovascular Research Foundation or the course directors of this activity.
In accordance with the accredited continuing education sponsored by Cardiovascular Research Foundation (CRF), all planners, teachers, and authors with control over activity content are required to disclose to the provider any relevant financial relationships (those held by the planner, currently or within the last 24 months) with ineligible companies. Accredited providers are required to provide this information to learners before the start of an activity.
KEY: (G/R) Grant Support/Research Contract (C/H/S) Consultant Fee/Honoraria/Speaker’s Bureau (E/S/O) Equity/Stock(s)/Options (R/I) Royalty/Intellectual Property Rights (S) Salary/Salary Support (O) Other Financial Benefit
Chairs:
Rebecca T. Hahn, MD, (C/H/S) - Abbott Vascular, Edwards Lifesciences, Boston Scientific Corporation, Navigate, Phillips Healthcare
Scott Lim, MD , (G/R) - Abbott Vascular, Boston Scientific Corporation, Edwards Lifesciences, Medtronic (C/H/S) W.L. Gore & Associates, Valgen, Venus, Philips
Faculty:
Linda D. Gillam, MD – (G/R) Edwards Lifesciences, Medtronic (C/H/S) Edwards Lifesciences, Philips (E/S/O) 4C
Jörg Hausleiter, MD – (C/H/S) (Both) Edwards Lifesciences
Konstantinos Koulogiannis, MD – (E/S/O) 4C (G/R) Edwards Lifesciences (C/H/S) Abbott Vascular
Azeem Latib, MD – (C/H/S) Abbott Vascular, Medtronic, Edwards Lifesciences, Supira, CorFlow, PiCardia
Leo Marcoff, MD – (G/R) Edwards Lifesciences, Medtronic (E/S/O) 4C
Brian K. Whisenant, MD – (C/H/S) Boston Scientific Corporation, Coherex Medical, Edwards Lifesciences, Abbott Vascular
Leora Yarboro, MD – (C/H/S) Medtronic
Content Reviewer(s):
Gary S. Mintz, MD — Consultant Fee/Honoraria/ Speaker’s Bureau – Boston Scientific Corporation, Abiomed
Grzegorz L. Kaluza, MD, PhD — Grant Support/Research Contract: Abbott Vascular; Abiomed, Medtronic; 4C Medical; Dura Biotech; InQB8; Ancora Heart; InnovHeart; Mitria; Thubrikar Aortic Valve; Terumo Medical Corporation; Bristol-Myers Squibb; Edwards Lifesciences; Alucent Biomedical; Advanced NanoTechnologies; Adriakaim; Thrombolex; Reflow Medical; Tenaya Therapeutics; Renovacor; Shape Memory Medical; Impulse Dynamics; Occlutech; Neochord; MicroInterventional Devices; Lungpacer; Inozyme; HLT; Deinde Medical; Autonomix; Cardiac Implants; Cagent Medical; Intact Vascular; OncoSec; Soundbite Medical Solutions; VasoRx; LivaNova; Encore Medical; Recardia; Cook Medical; StrideBio; Ethicon, a J&J Company.
Donald Cutlip, MD – Nothing to disclose
Anjelica Scaletta-Resias – Nothing to disclose
Thaifa Smith – Nothing to disclose
CME Independent Review
As a CME provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), CRF is committed to ensuring a fair, balanced view of diagnostic and therapeutic options, and scientific rigor in all its sponsored programs. As such, CRF’s Planning Committee has selected CME associate course directors to provide oversight of the program development planning process to ensure fair, balanced, free of commercial bias, including mitigation of any relevant financial relationships with ineligible companies for planners, faculty and others in control of educational content.
CRF identifies relevant financial relationships and mitigates them before the activity begins.
The CME associate course directors documented that all relevant financial relationships have been mitigated as of December 12, 2022.
This program is sponsored by the Cardiovascular Research Foundation and supported through an unrestricted educational grant by Edwards Lifesciences. The Cardiovascular Research Foundation ensures that its programs are educational and meet the needs of the target audience. This program was developed without influence from commercial supporters.